Abstract:Hypoxia inducible factor-1α (HIF-1α) is overexpressed in various types of solid tumor in humans, including bladder cancer. HIF-1α regulates the expression of a series of genes, which are involved in cell proliferation, differentiation, apoptosis, angiogenesis, migration and invasion and represents a potential therapeutic target for the treatment of human cancer. Despite extensive investigation of the effects of HIF-1α in the progression and metastasis of bladder cancer, the possible regulatory mechanisms underlying the effects of HIF-1α on bladder cancer cell proliferation and differentiation remain to be elucidated. It has been suggested that the transcription factor CCAAT/enhancer binding protein α (C/EBPα) acts as a tumor suppressor in several types of cancer cell, which are involved in regulating cell differentiation, proliferation and apoptosis. The present study confirmed that, in bladder cancer cells, the expression and localization of C/EBPα was regulated by hypoxia through an HIF-1α -dependent mechanism, which may be significant in bladder cancer cell proliferation and differentiation. The 5637 and T24 bladder cancer cell lines were incubated under normoxic and hypoxic conditions. The expression levels of HIF-1α and C/EBPα were detected by reverse transcription-quantitative polymerase chain reaction, western blotting and immunofluorescence analysis. The results revealed that, under hypoxic conditions, the protein expression levels of HIF-1α were markedly upregulated, but the mRNA levels were not altered. However, the mRNA and protein levels of C/EBPα were significantly reduced. The present study further analyzed the subcellular localization of C/EBPα, which was markedly decreased in the nuclei under hypoxic conditions. Following HIF-1α small interference RNA silencing of HIF-1α, downregulation of C/EBPα was prevented in the bladder cancer cells cultured under hypoxic conditions. In addition, groups of cells treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, which inhibits the expression of HIF-1α in hypoxia, contributed to the inhibited expression of HIF-1α and enhanced expression of C/EBPα in hypoxic bladder cancer cells. These results suggested that C/EBPα was a downstream effector regulated by HIF-1α in hypoxic bladder cancer cells and that this regulatory pathway may represent a potential therapeutic target in the treatment of bladder cancer.

BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α

BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.

Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia

Hif-1 Alpha Activates Hypoxia-Induced Bcl-9 Expression In Human Colorectal Cancer Cells

Lipid metabolism regulated by hypoxia inducible factor-1α in prostate cancer

Hypoxia Increases Cx3cr1 Expression Via Hif-1 And Nf-Kappa B In Androgen-Independent Prostate Cancer Cells

Hypoxia-inducible factor-1α regulates chemokine receptor type 4 to activate AKT/mTOR pathway to promote the viability and migration of diffuse large B cell lymphoma cells

Biological Characteristics of Prostate Cancer Cells Are Regulated by Hypoxia-Inducible Factor 1Α

BCLAF1-induced HIF-1 Α Accumulation under Normoxia Enhances PD-L1 Treatment Resistances Via BCLAF1-CUL3 Complex

Hypoxia increases CX 3 CR 1 expression via HIF-1 and NF-κ B in androgen-independent prostate cancer cells

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells

Identification of Cathepsin B As a Novel Target of Hypoxia-Inducible Factor-1-alpha in HepG2 Cells.

Hypoxia Regulates the Expression and Localization of CCAAT/enhancer Binding Protein Α by Hypoxia Inducible Factor-1Α in Bladder Transitional Carcinoma Cells

β-catenin nuclear translocation induced by HIF-1α overexpression leads to the radioresistance of prostate cancer

Transcriptional Regulation of FoxM1 by HIF‑1α Mediates Hypoxia‑induced EMT in Prostate Cancer.

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma

Hypoxia-inducible Factor -1Α in Prostate Cancer: Expression and Significance

Suppression of Bcl-xL Expression by a Novel Tumor-Specific RNA Interference System Inhibits Proliferation and Enhances Radiosensitivity in Prostatic Carcinoma Cells

Identification of Genes Involved in Adaptive Response to Hypoxia and Their Expression Attenuations by Gene Silencing of HIF-1α in A549 Lung Cancer Cells

HIF‐1α Mediates CXCR4 Transcription to Activate the AKT/mTOR Signaling Pathway and Augment the Viability and Migration of Activated B Cell‐like Diffuse Large B‐cell Lymphoma Cells